uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip

uniQure N.V. (NASDAQ: QURE)


$15.9000
-0.0200 ( -1.06% ) 0.1K

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Market Data


Open


$15.9000

Previous close


$15.9200

Volume


0.1K

Market cap


$780.49M

Day range


$15.6200 - $16.4490

52 week range


$3.7300 - $19.1800

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Aug 01, 2024
10-q Quarterly Reports 72 Aug 01, 2024
8-k 8K-related 15 Jul 23, 2024
8-k 8K-related 15 Jul 09, 2024
8-k 8K-related 15 Jul 01, 2024
4 Insider transactions 1 Jun 28, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024

Latest News